Dr Jose L Merino (Director, Arrhythmia-Electrophysiology Research Unit, Hospital General Universitario La Paz, Madrid, Spain) discusses the current challenges, treatment options, unmet clinical needs and recurrence rate for idiopathic ventricular tachycardia (VT) and premature ventricular complexes (PVC). Part 1 of 3.
Filmed at ESC 2018, Munich.
View more content here.
Speaker Disclosure: Dr Jose L Merino has the following disclosures in relation to this video interview: Abbott: educational contracts, advisory board, research contracts, speaker fees. Biosense: educational contracts. Biotronik: advisory board, research contracts. Boston Scientific: advisory board, fellows grants. Medtronic: fellows grants.
1. What are the current challenges of treating patients with idiopathic ventricular tachycardia (VT) and premature ventricular complexes (PVC)? (0:09)
2. How do you identify the patients most at risk of VT and PVC? (0:09)
3. What recent progress has been made in the treatment options for patients with VT and PVC? (1:29)
4. What are the current unmet clinical needs for identifying and treating patients with VT and PVC? (0:09)
5. What is the recurrence rate for VT and PVC following successful treatment via medication or ablation? (2:11)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via open-access content in multimedia formats.
Share this Video
Related Videos In Arrhythmia
David Albert: Why is the Arrhythmia Alliance so unique?
Dr David Albert (AliveCor, Mountain View, CA, USA) discusses why the Arrhythmia Alliance is so important in being patient driven, advocacy focussed and professionally engaged. For more information click here. Disclosures: David Albert is an employee and major stock shareholder of AliveCor. Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie […]
David Albert: Why is the Heart Rhythm Congress so important?
As the Heart Rhythm Congress 2022 has just finished, Dr David Albert (AliveCor, Mountain View, CA, USA) shares why the conference is so important in bringing together physicians, nurses, patients, patients advocates and all those interested in the care and diagnosis of arrhythmia patients. Disclosures: David Albert is an employee and major stock shareholder of […]
Shouvik Haldar: Get ready for Heart Rhythm Congress 2022!
Dr Shouvik Haldar (Royal Brompton & Harefield Hospitals, London, UK and Programme Director for Heart Rhythm Congress 2022) reveals a taster into what there is in store at the first in-person Heart Rhythm Congress since the COVID-19 pandemic. It is aimed for all individuals included in heart rhythm care and he is particularly looking forward to […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!